- Clinical application of liver stiffness measurement for assessing the risk of hepatocellular carcinoma
-
Yoo JJ, Jung EA, Kim SG
- KMID: 2448272
- J Liver Cancer.
- 2019 Mar;19(1):12-18.
- doi: 10.17998/jlc.19.1.12
The most significant risk factor for hepatocellular carcinoma (HCC) is the presence of cirrhosis or advanced fibrosis of the liver. Liver biopsy was traditionally considered the gold standard for assessing... -
- CITED
-
- Close
- SHARE
-
- Close
- Liver Transplantation after Successful Downstaging with Hepatic Arterial Infusion Chemotherapy in a Patient with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
-
Nam HC, Sung PS, Chun HJ, Kim DG, Jang JW, Choi JY, Yoon SK
- KMID: 2448279
- J Liver Cancer.
- 2019 Mar;19(1):64-68.
- doi: 10.17998/jlc.19.1.64
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. The majority of patients with HCC are diagnosed at advanced disease stages with vascular invasion, where curative approaches are... -
- CITED
-
- Close
- SHARE
-
- Close
- Gallbladder Fistula Treated with N-Butyl-2-Cyanoacrylate after Radiofrequency Ablation in a Hepatocellular Carcinoma Patient: a Case Report
-
So IT, Jang BK, Hwang JS, Kim YH
- KMID: 2448280
- J Liver Cancer.
- 2019 Mar;19(1):69-73.
- doi: 10.17998/jlc.19.1.69
Radiofrequency ablation (RFA) is a minimally invasive local therapy for hepatocellular carcinoma (HCC). Even though RFA is considered to be a safe treatment modality, a variety of complications have been... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Spontaneous Rupture of Hepatocellular Carcinoma Supplied by the Right Renal Capsular Artery Treated by Transcatheter Arterial Embolization
-
Jang JY, Jeon UB, Kim JH, Kim TU, Ryu H, Cho M, Hong YM, Kim M
- KMID: 2448278
- J Liver Cancer.
- 2019 Mar;19(1):59-63.
- doi: 10.17998/jlc.19.1.59
We present a case of spontaneous rupture of hepatocellular carcinoma with poor liver function managed by transcatheter arterial embolization (TAE). The patient's bilirubin level was 2.1 mg/dL, albumin level was... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic Failure Due to Hepatitis E Virus Infection in a Patient with Necrotic Hepatocellular Carcinoma
-
Kim JH, Doh YS, Jang JW, Kang MS, Kim NM, Kim SH, Baek IH, Jung SH
- KMID: 2448277
- J Liver Cancer.
- 2019 Mar;19(1):55-58.
- doi: 10.17998/jlc.19.1.55
In patients with hepatocellular carcinoma (HCC) or liver cirrhosis (LC) accompanied by hepatitis E virus (HEV) infection, hepatic failure often leads to debility. Here, we report about a 63-year-old man... -
- CITED
-
- Close
- SHARE
-
- Close
- Conventional Chemoembolization for Hepatocellular Carcinoma: Role of Cone-Beam Computed Tomography Guidance
-
Lee IJ, Chung JW
- KMID: 2448273
- J Liver Cancer.
- 2019 Mar;19(1):19-29.
- doi: 10.17998/jlc.19.1.19
Conventional chemoembolization using Lipiodol-based regimens was introduced in the 1980s, and it is currently recommended as the primary treatment modality for patients with unresectable, intermediate, or locally advanced hepatocellular carcinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances and Future Directions in Immunotherapeutics for Hepatocellular Carcinoma
-
Cho Y, Han J, Kim W
- KMID: 2448271
- J Liver Cancer.
- 2019 Mar;19(1):1-11.
- doi: 10.17998/jlc.19.1.1
Systemic target therapeutic drugs, such as sorafenib, lenvatinib, or regorafenib are the only drugs that are known to be effective against advanced hepatocellular carcinoma (HCC). However, these agents show a... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination Therapy of Angiotherapy, Radiation Therapy, and Radiofrequency Ablation for Pulmonary Metastasis of Hepatocellular Carcinoma Accompanied by Nontuberculous Mycobacteria
-
Park SH, Kim SK, Kim JH, Seo S, Hong HP, Ham SY, Kim BI
- KMID: 2448282
- J Liver Cancer.
- 2019 Mar;19(1):79-84.
- doi: 10.17998/jlc.19.1.79
With the advances in hepatocellular carcinoma (HCC) treatment, the lung metastasis of HCC is becoming increasingly important. In treating the lung metastasis of HCC, a multidisciplinary approach can lead to... -
- CITED
-
- Close
- SHARE
-
- Close
- Discrepancy between the Actual Clinical Status of Patients with Hepatocellular Carcinoma and Expectations from Hepatocellular Carcinoma Surveillance: a Single-Center Study
-
Kim NM, Doh YS, Jang JW, Kim SH, Eun HS, Jun JH, Kim SH, Baek IH, Jung SH
- KMID: 2448274
- J Liver Cancer.
- 2019 Mar;19(1):30-37.
- doi: 10.17998/jlc.19.1.30
BACKGROUND/AIMS: The National Liver Cancer Screening Program (NLCSP) has been implemented for the past 15 years in Korea. However, the actual clinical experience in Korea is inconsistent with the expectations... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of PTEN Polymorphism on the Development of Hepatitis B Virus-associated Hepatocellular Carcinoma
-
Kim SS, Eun JW, Cho HJ, Lee HY, Seo CW, Lee GH, Yoon SY, Noh CK, Cho SW, Cheong JY
- KMID: 2448276
- J Liver Cancer.
- 2019 Mar;19(1):46-54.
- doi: 10.17998/jlc.19.1.46
BACKGROUND/AIMS: Phosphatase and tensin homolog (PTEN) is a known tumor suppressor gene that is downregulated in hepatocellular carcinoma (HCC). Here, we investigated the association between single nucleotide polymorphisms (SNPs) of... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Achieving Partial Remission with the Combination of Sorafenib and Nivolumab in a Patient with Hepatocellular Carcinoma Showing Disease Progression after Nivolumab Therapy
-
Hwang SY, Lee SM, Im JW, Jeon KJ, Choi CW, Kim KS, Jeon W
- KMID: 2448281
- J Liver Cancer.
- 2019 Mar;19(1):74-78.
- doi: 10.17998/jlc.19.1.74
Sorafenib is a well-known approved systemic therapeutic agent used in patients with advanced hepatocellular carcinoma (HCC). Regorafenib and nivolumab are approved as second-line therapeutic drugs in patients showing disease progression... -
- CITED
-
- Close
- SHARE
-
- Close
- High-dose versus Low-dose 5-Fluorouracil and Cisplatin Based Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma
-
Lim CJ, Hong JY, Ko YS, Chung MW, Jun CH, Choi SK, Cho SB
- KMID: 2448275
- J Liver Cancer.
- 2019 Mar;19(1):38-45.
- doi: 10.17998/jlc.19.1.38
BACKGROUND/AIMS: Hepatic arterial infusion chemotherapy (HAIC) has been reported as an effective treatment for advanced hepatocellular carcinoma. The aim of this study is to compare the effect and safety between... -
- CITED
-
- Close
- SHARE
-
- Close
